Implementation Science: Economics & Costs in Cancer Research

Date: Wednesday, April 29, 2020

Time: 2:00 - 3:00 PM ET

Category: Priority Topic

The lack of economic and cost-effectiveness analyses within the implementation science portfolio, highlights a need to focus on methodological and measurement issues, as well as field capacity, to better understand what the implementation costs are and who bears them, and to distinguish between the intervention versus implementation costs. This webinar discusses how these questions were addressed at the first Implementation Science Consortium in Cancer (ISCC) in 2019 and next steps for the field. 

Presenters

Dr. Heather Taffet Gold

Dr. Heather Taffet Gold

Organization: NYU Langone Health

Dr. Gila Neta

Dr. Gila Neta

Organization: National Cancer Institute

Dr. Todd Wagner

Dr. Todd Wagner

Organization: Stanford University